Increased serum C3 levels in Crry transgenic mice partially abrogates its complement inhibitory effects.

Kang, H J; Bao, L; Xu, Y; Quigg, R J; Giclas, P C; Holers, V M

Kang, H J; Bao, L; Xu, Y; Quigg, R J; Giclas, P C; Holers, V M.

Affiliation

Kang HJ; Department of Laboratory Medicine, Hallym University College of Medicine, Anyang, Korea. kangheejung@hallym.or.kr

Clin Exp Immunol ; 136(2): 194-9, 2004 May.

Article in En | MEDLINE | ID: mdl-15086380

Subject(s)

Complement C3/metabolism; Complement Pathway, Alternative; Receptors, Complement/metabolism; Animals; Complement Factor B/analysis; Complement Factor D/analysis; Complement Factor H/analysis; Flow Cytometry; Gene Expression; Mice; Mice, Transgenic; Receptors, Complement/analysis; Receptors, Complement/genetics; Receptors, Complement 3b; Zinc/administration & dosage; Zymosan

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Complement C3 / Receptors, Complement / Complement Pathway, Alternative Type of study: Prognostic_studies Limits: Animals Language: En Journal: Clin Exp Immunol Year: 2004 Document type: Article

Fulltext

XML

PubMed Links

Search on Google